Suppr超能文献

通过miR-340-5p靶向FHL2-E-钙黏蛋白轴可减弱结肠癌细胞的迁移和侵袭。

Targeting FHL2-E-cadherin axis by miR-340-5p attenuates colon cancer cell migration and invasion.

作者信息

Algaber Anwar, Madhi Raed, Hawez Avin, Rönnow Carl-Fredrik, Rahman Milladur

机构信息

Department of Clinical Sciences, Malmö, Section for Surgery, Lund University, 214 28 Malmö, Sweden.

Department of Biology, College of Science, University of Misan, Maysan 62001, Iraq.

出版信息

Oncol Lett. 2021 Aug;22(2):637. doi: 10.3892/ol.2021.12898. Epub 2021 Jul 3.

Abstract

Convincing data has suggested that four and a half LIM domain 2 protein (FHL2) serves a key function in cancer cell metastasis and that microRNA (miR)-340-5p can regulate cancer cell migration. The current study hypothesized that targeting FHL2 expression by miR-340-5p in colon cancer may attenuate colon cancer cell migration and invasion. FHL2 expression was therefore assessed in colon cancer microarray datasets using Qlucore omics explorer as well as in HT-29 and AZ-97 colon cancer cell lines via reverse transcription-quantitative PCR (RT-qPCR). Colon cancer cell migration and invasion were evaluated in the presence of miR-340-5p mimic, mimic control or mimic with a target site blocker. Confocal microscopy and RT-qPCR were subsequently performed to assess FHL2, E-cadherin (E-cad) protein and mRNA expression in colon cancer cells. Microarray dataset analysis revealed that FHL2 expression was lower in primary colon cancer cells compared with normal colonic mucosa. It was revealed that the expression of miR-340-5p and FHL2 were inversely related in serum-grown and low-serum conditions in HT-29 and AZ-97 cells. Short-time serum exposure to low-serum grown cells induced FHL2 expression. Transfection of HT-29 cells with miR-340-5p mimic not only decreased serum-induced expression of FHL2 but also decreased cancer cell migration and invasion. Bioinformatics analysis revealed that FHL2 mRNA had one putative binding site for miR-340-5p at the 3-untranslated region. Blocking of the target site using a specific blocker reverted miR-340-5p mimic-induced inhibition of FHL2 expression and cancer cell migration and invasion. Confocal microscopy confirmed that the reduction of FHL2 expression by miR-340-5p mimic also reversed serum-induced E-cad disruption and that the target site blocker abrogated the effect of miR-340-5p. The current results suggested that miR-340-5p could be used to antagonize colon cancer cell metastasis by targeting the FHL2-E-cad axis.

摘要

有说服力的数据表明,四又二分之一LIM结构域2蛋白(FHL2)在癌细胞转移中起关键作用,且微小RNA(miR)-340-5p可调节癌细胞迁移。当前研究假设,在结肠癌中通过miR-340-5p靶向FHL2表达可能会减弱结肠癌细胞的迁移和侵袭。因此,使用Qlucore组学浏览器在结肠癌微阵列数据集中评估FHL2表达,并通过逆转录定量PCR(RT-qPCR)在HT-29和AZ-97结肠癌细胞系中评估FHL2表达。在存在miR-340-5p模拟物、模拟物对照或带有靶位点阻断剂的模拟物的情况下,评估结肠癌细胞的迁移和侵袭。随后进行共聚焦显微镜检查和RT-qPCR,以评估结肠癌细胞中FHL2、E-钙黏蛋白(E-cad)的蛋白和mRNA表达。微阵列数据集分析显示,与正常结肠黏膜相比,原发性结肠癌细胞中FHL2表达较低。结果显示,在HT-29和AZ-97细胞的血清培养和低血清条件下,miR-340-5p与FHL2的表达呈负相关。短期血清暴露于低血清培养的细胞会诱导FHL2表达。用miR-340-5p模拟物转染HT-29细胞不仅会降低血清诱导的FHL2表达,还会降低癌细胞的迁移和侵袭。生物信息学分析显示,FHL2 mRNA在3'非翻译区有一个假定的miR-340-5p结合位点。使用特异性阻断剂阻断靶位点可逆转miR-340-5p模拟物诱导的FHL2表达抑制以及癌细胞的迁移和侵袭。共聚焦显微镜检查证实,miR-340-5p模拟物降低FHL2表达也可逆转血清诱导的E-cad破坏,且靶位点阻断剂可消除miR-340-5p的作用。当前结果表明,miR-340-5p可通过靶向FHL2-E-cad轴来拮抗结肠癌细胞转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff53/8273858/a82dc678bd0e/ol-22-02-12898-g00.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验